ConductScience.org, home

Paper41228343

Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.

Fasano M and 20 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer. Papers, record 41228343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41228343

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-16
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fasano MMorenahttps://orcid.org/0000-0003-0782-8778
2Perri FFrancescohttps://orcid.org/0000-0001-8158-7509
3Pirozzi MMario
4Deantoni CLChiara Lucreziahttps://orcid.org/0000-0002-3610-0316
5Valsecchi DDavide
6Cirillo AAlessiohttps://orcid.org/0000-0003-0449-9569
7Addeo RRaffaelehttps://orcid.org/0000-0001-9197-8060
8Vitale PPasquale
9De Felice FFrancescahttps://orcid.org/0000-0002-5119-8358
10Tralongo PPaolo
11Farese SStefano
12Ruffilli BBeatrice
13Romano FFabrizio
14Guizzardi MMathilda
15Giordano LLeonehttps://orcid.org/0000-0001-9094-4205
16Pontone MMonica
17Marciano MLMaria Luisahttps://orcid.org/0000-0003-4095-1022
18Rampetta FRFabiana Raffaella
19Longo FFrancescohttps://orcid.org/0000-0002-7605-2953
20Ciardiello FFortunato

Source PubMed

See all 21 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123026829Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.Lancet Oncol2012https://conductscience.org/library/papers/23026829PubMed
230828911Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.Head Neck2019https://conductscience.org/library/papers/30828911PubMed
316012181Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors.Ann Oncol2005https://conductscience.org/library/papers/16012181PubMed
420530316Human papillomavirus and survival of patients with oropharyngeal cancer.N Engl J Med2010https://conductscience.org/library/papers/20530316PubMed
533150521Prospective practice survey of management of cetuximab-related skin reactions.Support Care Cancer2021https://conductscience.org/library/papers/33150521PubMed
619289626Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.J Clin Oncol2009https://conductscience.org/library/papers/19289626PubMed
712506176An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.J Clin Oncol2003https://conductscience.org/library/papers/12506176PubMed
818559875Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.J Clin Oncol2008https://conductscience.org/library/papers/18559875PubMed
931015170The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis.Radiother Oncol2019https://conductscience.org/library/papers/31015170PubMed
1019446902Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.Radiother Oncol2009https://conductscience.org/library/papers/19446902PubMed
1119699545Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.Radiother Oncol2009https://conductscience.org/library/papers/19699545PubMed
1219524312Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.Radiother Oncol2009https://conductscience.org/library/papers/19524312PubMed
1322194030Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.Strahlenther Onkol2012https://conductscience.org/library/papers/22194030PubMed
1434098030Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.Int J Radiat Oncol Biol Phys2021https://conductscience.org/library/papers/34098030PubMed
1521110844Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.Head Neck Oncol2010https://conductscience.org/library/papers/21110844PubMed
1631242489Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study.Chemotherapy2019https://conductscience.org/library/papers/31242489PubMed
1714722034Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.J Clin Oncol2004https://conductscience.org/library/papers/14722034PubMed
1822250183Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.Ann Oncol2012https://conductscience.org/library/papers/22250183PubMed
1927212198Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.Int J Radiat Oncol Biol Phys2016https://conductscience.org/library/papers/27212198PubMed
2026553007G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.BMC Cancer2015https://conductscience.org/library/papers/26553007PubMed

See all 72 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41228343

GET https://conductscience.org/api/papers/v1/41228343/authors?page=2